DocWire News Editors

DocwireNews

Women with gestational diabetes (GDM), and their fetus, are at risk of adverse pregnancy and long-term outcomes. Sleep-disordered breathing (SDB) is observed in 17% to 45% of pregnancies; when adjusting for obesity, SDB is associated with about a threefold increased risk of GDM. Although a correlation has previously been established between SDB during pregnancy and elevated nocturnal glucose levels, it has not been determined whether continuous positive airway pressure (CPAP) improves glucose control in pregnancy. A study that was published online as part of the ATS 2020 International Conference used 24-hour continuous glucose monitoring (CGM) in pregnant women with CDM to ascertain whether CPAP helped with glucose control.The randomized, controlled trial included pregnant women from obstetrics clinics at two centers in Montreal, Canada who were diagnosed with GDM (per the World Health Organization 2013 criteria) and SDB (defined as apnea-hypopnea index [AHI] &ge;10 [Chicago Scoring Criteria]). A level-two home sleep study was performed to screen women for SDB. Women were randomized to one of two groups: auto-CPAP (experimental group) or nasal dilator strips (NDS; control group). Before and after the treatment period, women underwent CGM over a 72-hour period; mean 24-hour glucose values were calculated, as were mean glucose values from two time periods: 11 p.m. to 3 a.m. and 3 a.m. to 6 a.m.A total of 68 pregnant women with GDM (mean age, 35 years; mean body mass index, 32 kg/m2; mean gestation, 29 weeks) were identified and screened for SDB. A total of 45 patients (mean AHI, 22) with SDB were randomized, and 33 completed CGM before and after treatment: 15 in the experimental group and 18 in the control group. Women had an average treatment duration of 34 days; mean CPAP adherence was 3.3 hours per night. The average effect of treatment for CPAP compared with NDS for mean glucose values was &ndash;0.43 mmol/L for 24 hours, &ndash;0.59 mmol/L for 11 p.m. to 3 a.m., and &ndash;0.90 for 3 a.m. to 6 a.m.The study authors concluded that CPAP was associated with significant reductions in nocturnal glucose levels from 3 a.m. through 6.a.m. They called for future studies to include larger sample sizes.

Jordana Jampel

Cutaneous Melanoma: Sun Protection Behaviors and UV Exposure in Canada

Melanoma

Leah Lawrence

Significant Cardiac Benefit Seen With Ifetroban in Patients With Duchenne Muscular Dystrophy

Neurology

Apitegromab Improved Motor Function in Type 2/3 Spinal Muscular Atrophy

Latest News

CPAP Significantly Reduces Nocturnal Glucose Levels in Gestational Diabetes

ATS 2020 Conference Coverage

Women with gestational diabetes (GDM), and their fetus, are at risk of adverse pregnancy and long-term outcomes. Sleep-disordered breathing (SDB) is observed in 17% to 45% of ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe